Navigation Links
WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer

- Rawson to Oversee Scientific Integrity of WellGen Programs and Advance

Collaborations with Food and Beverage Industry Leaders -

NORTH BRUNSWICK, N.J., Dec. 18 /PRNewswire/ -- WellGen, Inc., a biotechnology company using nutrigenomics to discover and develop food ingredients for wellness products, today announced the appointment of Nancy E. Rawson, M.Sc., Ph.D., as Chief Scientific Officer. Dr. Rawson fills a newly created position that will report directly to the CEO.

Dr. Rawson, 51, joins WellGen at a critical stage in its development, as the Company has just brought its first functional food ingredient product to market and is conducting human studies for its second, while seeking to significantly expand the number of ingredients in its pipeline. In addition, the Company is completing the installation of a new, state-of-the-art molecular biology and natural products chemistry laboratory.

Dr. Rawson comes to WellGen with an extensive background in food, nutrition and basic biomedical research. Dr. Rawson most recently worked at the Monell Chemical Senses Center in Philadelphia, PA, as an Associate Member. The Monell Center is an independent scientific institute dedicated to basic research on the senses of taste, smell and chemosensory irritation. During her tenure there, Dr. Rawson built relationships with well-recognized leaders in the food and beverage industry as well as with researchers throughout the world.

Previously, Dr. Rawson was a Senior Nutrition Research Associate at the Campbell Soup Company. She also has held numerous advisory and university teaching positions.

Dr. Kathleen Mullinix, Chief Executive Officer of WellGen, said, "We are fortunate to have Nancy Rawson, who is an outstanding scientist, join our company, and we look to her to ensure that our products' scientific foundations will meet the very highest standards. Her background in both research and industry will also enable her to be an effective leader in working with partner companies to bring new functional foods and beverages to market."

Richard Morgan, CEO of Amphion Innovations plc (LSE: AMP), a leading investor in WellGen, said, "Nancy Rawson has an excellent reputation in the food industry and an exceptional track record of scientific accomplishments. These will help WellGen continue to establish its leading position in the growing functional foods and beverages industry."

During her career, Dr. Rawson has received numerous honors and awards in bioscience and nutrition, and has often been quoted in the media as an authority in these fields. She is a frequent lecturer and conference panelist, and has authored and collaborated on a wide range of publications for both academic and non-technical audiences. She graduated with a Bachelor of Science degree from Fairfield University, Fairfield, CT, earned a Masters of Science in Nutrition from the University of Massachusetts, Amherst, and received a Ph.D. in Biology from the University of Pennsylvania.

About Amphion Innovations plc

Amphion Innovations plc (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors. Amphion uses a focused, hands-on company building approach based on decades of experience in both the US and UK. On the web:

About WellGen

WellGen, Inc., based in North Brunswick, NJ, is a biotechnology company that is discovering and developing products for food, therapeutics, and dietary supplement markets with a strategic focus on functional foods. WellGen's proprietary technology platform is a method of screening the effect of food and related substances on the expression of genes associated with human health conditions. The company has developed proprietary substances that help maintain health and reduce risk and severity for a variety of diseases. Please visit our website at for more information.

SOURCE WellGen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Names Kerry Howell Vice President for Advancement
2. Vical Names Andrew de Guttadauro Vice President, Corporate Development
3. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
4. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
5. CryoLife Names Philip Theodore as Vice President, General Counsel
6. Genstar Names Michael Hurt to Its Strategic Advisory Board
7. PPD Names Daniel Darazsdi as Chief Financial Officer
8. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
9. Cadence Pharmaceuticals Names Malvina Laudicina Vice President of Regulatory Affairs and Quality Assurance
10. Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
11. Osprey Pharmaceuticals Names Jack M. Anthony as CEO
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:10/29/2015)... Daon, a global leader in mobile biometric ... new version of its IdentityX Platform , IdentityX ... have already installed IdentityX v4.0 and are ... FIDO UAF certified server component as an option ... features. These customers include some of the largest and ...
(Date:10/29/2015)... 29, 2015  Connected health pioneer, Joseph C. ... of technology-enabled health and wellness, and the business opportunities ... The Internet of Healthy Things . Long ... even existed, Dr. Kvedar, vice president, Connected Health, Partners ... delivery, moving care from the hospital or doctor,s office ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
Breaking Biology News(10 mins):